CHARLESTON, S.C. — When Web page Campbell’s physician advisable she strive an injectable prescription drug referred to as Wegovy to shed extra pounds earlier than scheduling bariatric surgical procedure, she readily agreed.
“I’ve struggled with my weight for therefore lengthy,” mentioned Campbell, 40, a single mom of two. “I’m not against making an attempt something.”
In early April, about 4 weeks after she’d began taking Wegovy, Campbell mentioned she hadn’t skilled any unwanted effects, corresponding to nausea or bowel irritation. However she doesn’t use a scale at residence, she mentioned, so she didn’t know whether or not she’d misplaced any weight since her most up-to-date medical appointment earlier this 12 months, when she weighed 314 kilos. Nonetheless, she was assured about attaining weight reduction.
“It’s going to work as a result of I’m placing within the work. I’m altering my consuming habits. I’m exercising,” mentioned Campbell, a transport supervisor at a Michaels retailer. “I’m not going to second-guess myself.”
Wegovy belongs to a dear class of medicine referred to as GLP-1s (brief for glucagon-like peptide-1 agonists) which have upended the remedy of weight problems lately, providing hope to sufferers who’ve tried and did not shed extra pounds in myriad different methods.
Campbell gained entry to Wegovy by way of South Carolina Medicaid’s resolution in late 2024 to cowl these weight reduction medicine. However the medicines stay out of attain for thousands and thousands of sufferers throughout the nation who may gain advantage from them, as a result of many private and non-private well being insurers have deemed the medicine too costly.
A report revealed in November by KFF, a well being data nonprofit that features KFF Well being Information, discovered solely 13 states have been overlaying GLP-1s for the remedy of weight problems for Medicaid beneficiaries as of August. South Carolina turned the 14th in November.
Liz Williams, one of many report’s authors and a senior coverage supervisor for the Program on Medicaid and the Uninsured at KFF, mentioned she was not conscious of some other state Medicaid applications becoming a member of the record since then. Trying forward, the remaining states could also be reluctant so as to add a brand new, costly drug profit whereas they brace for potential federal cuts coming from Congress, she mentioned.
“Because the funds debate, federally, is creating, which will affect how states are excited about this,” Williams mentioned.
The federal authorities received’t be serving to anytime quickly, both. Medicare covers GLP-1s to deal with diabetes and another well being situations, together with obstructive sleep apnea and heart problems, however not weight problems. In early April, the Trump administration introduced it is not going to finalize a rule proposed by the Biden administration that might have allowed an estimated 7.4 million individuals coated by Medicare and Medicaid to entry GLP-1s for weight reduction. In the meantime, the FDA is poised to drive cheaper, compounded variations of those medicine off the market.
And the barrier to entry stays excessive, even for Medicaid sufferers in these few states which have agreed to cowl the medicine with out a federal mandate.
Working example: In South Carolina, the place greater than one-third of all adults, and almost half of the African American inhabitants, qualify as overweight, the state Medicaid company estimates only one,300 beneficiaries will meet the stringent stipulations for GLP-1 protection.
Underneath a type of necessities, Medicaid beneficiaries who want to entry these medicine to shed extra pounds should attest to “elevated train exercise,” mentioned Jeff Leieritz, a spokesperson for the South Carolina Division of Well being and Human Companies.
Campbell, who’s insured by Medicaid, was granted protection for Wegovy based mostly on her physique mass index. First, although, she was required to submit six months’ price of documentation proving that she’d tried and did not shed extra pounds after receiving vitamin counseling and happening a 1,200-calorie-a day weight loss program, mentioned Kenneth Mitchell, one among Campbell’s docs and the medical director for bariatric surgical procedure and weight problems medication at Roper St. Francis Healthcare.
Campbell’s Wegovy prescription was authorised for six months, Mitchell mentioned. When that authorization expires, Campbell and her well being care crew might want to submit extra documentation, together with proof that she has misplaced no less than 5% of her physique weight and has stored up with vitamin counseling.
“It’s not simply, ‘Ship a prescription in they usually cowl it.’ It’s relatively arduous,” Mitchell mentioned. “Not quite a lot of people are going to do that.”
Mitchell mentioned South Carolina Medicaid’s resolution to cowl these medicine was met with pleasure amongst these working in his medical specialty. However he wasn’t stunned that the state anticipates comparatively few individuals will entry this profit yearly, for the reason that approval course of is so rigorous and the associated fee excessive. “The issue is the medicines are so costly,” Mitchell mentioned.
Novo Nordisk, which manufactures Wegovy, introduced in March that it was slicing the month-to-month value for the drug from $650 to $499 for cash-paying prospects. The worth that medical health insurance plans and beneficiaries pay for these medicine varies, however some GLP-1s value greater than $1,000 per affected person per thirty days, Mitchell mentioned, and many individuals might want to take them for the remainder of their lives to take care of weight reduction.
“That may be a super price ticket that somebody has to foot the invoice for,” Mitchell mentioned.
That’s the explanation California Gov. Gavin Newsom on Might 14 proposed eliminating Medicaid protection of GLP-1s for weight reduction beginning Jan. 1, to avoid wasting an estimated $680 million a 12 months by 2028.
And the North Carolina State Well being Plan Board of Trustees voted final 12 months to finish protection of GLP-1s for state staff, after then-North Carolina Treasurer Dale Folwell’s workplace estimated in 2023 that the medicine have been projected to value the State Well being Plan $1 billion over the following six years. The choice got here only some months after a separate North Carolina company introduced it could begin overlaying these medicine for Medicaid beneficiaries. North Carolina Medicaid has estimated it can spend $16 million a 12 months on GLP-1s.
South Carolina Medicaid, which insures fewer than half the variety of individuals enrolled in North Carolina Medicaid, anticipates spending much less. Leieritz estimated GLP-1s and vitamin counseling provided to Medicaid beneficiaries in South Carolina will value $10 million a 12 months. State funding will cowl $3.3 million of the expense; the rest will probably be paid for by matching Medicaid funds from the federal authorities.
In a latest interview, Well being and Human Companies Secretary Robert F. Kennedy Jr. didn’t rule out the likelihood that Medicare and Medicaid would possibly cowl GLP-1s for weight problems remedy sooner or later as prices come down.
They’re “extraordinary medicine” and “we’re going to cut back the associated fee,” Kennedy advised CBS Information in early April. He mentioned he would love GLP-1s to ultimately be made accessible to Medicare and Medicaid sufferers who’re in search of weight problems remedy after they’ve tried different methods to shed extra pounds. “That’s the framework that we’re now debating.”
In the meantime, public well being consultants have applauded South Carolina Medicaid’s resolution to cowl GLP-1s. But the brand new profit received’t assist the overwhelming majority of the 1.5 million adults in South Carolina who’re categorised as overweight, in keeping with knowledge revealed by the South Carolina Division of Public Well being.
“We nonetheless have some work to do,” acknowledged Brannon Traxler, the general public well being division’s chief medical officer.
However the state’s new “Motion Plan for Wholesome Consuming and Lively Dwelling,” written by a coalition of teams in South Carolina, together with the Division of Public Well being, makes no point out of GLP-1s or the function they may play in reducing weight problems charges within the state.
The motion plan, underwritten by a $1.5 million federal grant, isn’t meant to put out an overarching method for reducing weight problems in South Carolina, Traxler mentioned. As an alternative, it promotes bodily exercise in colleges, vitamin, and the growth of out of doors strolling trails, amongst different methods. A extra complete weight problems plan would possibly tackle the advantages of surgical intervention and GLP-1s, however these additionally carry threat, expense, and unwanted effects, Traxler mentioned.
“Actually, I feel, there’s a have to deliver all of it collectively,” she mentioned.
Campbell, for one, is taking the great method. On high of injecting Wegovy as soon as weekly, she mentioned, she is prioritizing protein consumption and shifting her physique. She additionally underwent weight reduction surgical procedure in late April.
“Weight reduction is my largest purpose,” mentioned Campbell, who expressed appreciation for Medicaid’s protection of Wegovy. “It’s another factor that’s going to assist me get to my purpose.”
